Results 111 to 120 of about 5,946 (190)

Postmarketing analysis of sotatercept: identifying serious unlabelled events. [PDF]

Open Heart
Cao Z, Xiao Q, Li X, Zhang H, Zhang M.
europepmc   +1 more source

Postmarketing safety surveillance for GSK's AS01_E-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety study. [PDF]

BMJ Open
Adimadhyam S, Luyts D, Oraichi D, Deraedt Q, Pircon JY, Bilker WB, Agan AA, Rajbhandari R, Carbonari DM, Djibo DA, Wang X, Nolan MB, DeVries A, Selvan M, Ma Q, Wentz AE, Daniels K, Platt R, Lo Re V, Cocoros NM.   +19 more
europepmc   +1 more source

Postmarketing Research for Opioid Abuse-Deterrent Formulations: A Narrative Review. [PDF]

J Pain Res
Webster L, Gudin J, Green JL, Argoff CE.
europepmc   +1 more source

Real-world safety assessment of avacopan in patients with antineutrophil cytoplasmic antibody-associated vasculitis. [PDF]

RMD Open
Han XY, Li ZY, Chen SF, Zhao MH, Little MA, Chen M.   +5 more
europepmc   +1 more source

From a pyramid to an amphitheatre (triangle to circle): embracing the totality of evidence for the postmarketing evaluation of the safety of therapeutic interventions. [PDF]

BMJ Open
Shakir S, Lane S.
europepmc   +1 more source

Safety Evaluation of Omniscan: An Observational Postmarketing Surveillance. [PDF]

Cureus
Mahajan H, Batta NS, Vaze P, Shad PS, Mahajan K, Hibberd MG, Roessink B, Dunham DM, Sahni J, Pandey R.   +9 more
europepmc   +1 more source

Evolution of biological agents: how established drugs can become less safe [PDF]

, 2017
Casadevall, Nicole, Flossmann, Oliver, Hunt, David   +2 more
core   +1 more source

Challenges and future perspectives of enhanced passive safety surveillance of influenza vaccines in Europe. [PDF]

Ther Adv Drug Saf
Amaral de Avila Machado M, Gandhi-Banga S, Serradell L, Gallo S, Wagué S, Moore TM, Khromava A.   +6 more
europepmc   +1 more source

FDA Adverse Event Reporting System (FAERS) Essentials: A Guide to Understanding, Applying, and Interpreting Adverse Event Data Reported to FAERS. [PDF]

Clin Pharmacol Ther
Potter E, Reyes M, Naples J, Dal Pan G.
europepmc   +1 more source

Anaphylaxis and glatiramer acetate. [PDF]

Mult Scler
Kim TB, Lee JY, Brinker A, Lee PR, Baldassari LE, Pimentel Maldonado DA, Hughes A, Chan V.   +7 more
europepmc   +1 more source